Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 1 medicine · Historical list
All medicines with Haemophilus b conjugate
Every register, a page at a time. Strengths and packs are on each medicine’s page.
21 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Haemophilus B Conjugate Vaccine (Diphtheria Toxoid-Conjugate) Prohibit | Taiwan | 注射劑 | Cancelled | 法台化學股份有限公司 | |
| ComvaxCombination | United States | 7.5UG PRP/125UG OMPC/5UG HBsAg | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Hiberix | United States | 10UG/25UG | For Injection | Marketed | GlaxoSmithKline Biologicals |
| Acthib,Omnihib | United States | 24UG | For Injection | Marketed | Sanofi Winthrop Industrie |
| Pedvaxhib | United States | 7.5UG/.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| PentacelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| Hibtiter, Haemophilus B Conjugate Vaccine (Diphtheria CRM197)Combination | Taiwan | 注射劑 | Cancelled | 臺灣惠氏股份有限公司 | |
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Infanrix-Ipv/HibCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| MenhibrixCombination | United States | 0.5ML | Injection | Withdrawn | GlaxoSmithKline Biologicals |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Pentaxim VaccineCombination | Singapore | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Hexavac | European Union | Withdrawn | Sanofi Pasteur MSD, SNC | ||
| Procomvax | European Union | Cancelled | Sanofi Pasteur MSD, SNC | ||
| Quintanrix | European Union | Withdrawn | GlaxoSmithKline Biologicals S.A. | ||
| Hiberix | Canada | 10 MCG / 0.5 ML | Powder For Solution | Cancelled | Glaxosmithkline INC |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1



